You are here
This Policy outlines the processes by which the Independent Hospital Pricing Authority stabilises volatility in the year-on-year price weights and adjustments to ensure funding stability and predictability for local hospital networks and hospital managers.
The Management of Confidential Jurisdictional Information Protocol outlines the limited and prescribed purpose for which the Independent Hospital Pricing Authority can collect and analyse confidential jurisdictional information and the processes and controls in place to prevent unauthorised access and disclosure to unauthorised parties.
The Independent Hospital Pricing Authority (IHPA) is responsible for relevant data collections to enable activity based funding. IHPA’s Data Access and Release Policy outlines the principles and processes adopted by IHPA in the discretionary access and release of data collected under the National Health Reform Act 2011. The Policy provides guidance as to how IHPA will determine whether to release data.
The Assessing Materiality of Changes Proposed to the National Pricing Model document outlines the process the Independent Hospital Pricing Authority follows when assessing the materiality of proposed refinements to the national pricing model, such as new adjustments for specific cohorts of patients or the application of modified pricing approaches.
A jurisdiction may request the Independent Hospital Pricing Authority (IHPA) to consider any legitimate and unavoidable costs in the delivery of public hospital services. The purpose of this Framework is to outline the process by which IHPA will assess submissions from jurisdictions on legitimate and unavoidable cost variations and determine whether adjustments to the national efficient price are warranted.
This Framework outlines the processes to investigate cross-border and cost-shifting disputes following a request by a health minister to ensure the timely, equitable and transparent management of these disputes.
There are three key publications that support the Tier 2 Non-Admitted Services Classification.
Tier 2 Non-Admitted Services Definitions Manual: This document provides the structural overview of the classification and the definition of each of the Tier 2 classes.
The Pricing Framework for Australian Public Hospital Services 2021–22 (the Pricing Framework) is the key strategic document underpinning the national efficient price (NEP) and national efficient cost (NEC) Determinations for the financial year 2021–22 (NEP21 and NEC21 respectively).
Report for the counting, costing and classifying of Non-Admitted Multidisciplinary Case Conferences (MDCCs) where patient is not present17 May 2017
IHPA commissioned a study of the counting, costing and classifying of multidisciplinary case conferences (MDCCs) for non-admitted patients, when the patient is not present. MDCCs have become a more common and important aspect of clinical care. The increasing complexity and specialisation in health care has driven the need for more formalised mechanisms for multidisciplinary collaboration.
The purpose of this costing study was to undertake a Teaching, Training and Research (TTR) cost and activity data collection at a representative sample of Australian hospitals and produce costed data to inform the development of a TTR classification.
This document provides information for clinicians to enable them to assess phases accurately when applying the new concept of mental health phase of care.
As prescribed in Section 225 of the National Health Reform Act 2011 (the Act), the objectives of the IHPA Work Program are to:
- set out IHPA’s work program for the coming year; and
- invite interested persons (including states and territories) to make submissions to the Pricing Authority about the work program up to 30 days after publication.
An extract of Section 225 of the Act is attached at Appendix 1
This document describes the Australian Mental Health Care Classification and the process IHPA has undertaken to develop the new classification.
The Independent Hospital Pricing Authority is committed to providing the Australian health care industry with a nationally consistent method of classifying all types of patients, their treatment and associated costs. Consequently, resources continue to be devoted to the ongoing development of a Diagnosis Related Groups (DRG) classification system based on local clinical practice.